Cardiovascular

Preconception Blood Pressure and Sex of the Baby: A Large Prospective Cohort Study in China

Figura científica PMC13477434

Flowchart of participants. Flowchart showing the process of participant selection and exclusion from the China‐US Collaborative Project for Neural Tube Defects Prevention. Participants were subsequently categorized into different blood pressure categories to examine the association between preconception blood pressure and sex of the baby.

Fuente oficial abierta: NCBI/PMC (PMC13477434)

Preconception Maternal Hemodynamics and Offspring Sex Determination: Molecular Mechanisms Underlying Sex-Dimorphic Blastocyst Selection



Abstract


Maternal preconception physiology exerts a decisive influence on early reproductive outcomes, yet the biological interplay between pre-pregnancy cardiovascular parameters and the secondary sex ratio remains incompletely understood. Recent large-scale prospective cohort data demonstrate a statistically significant positive association between elevated maternal preconception blood pressure—specifically systolic blood pressure—and the probability of delivering a male infant. This manuscript explores the underlying cellular and molecular mechanisms governing this phenomenon, focusing on endometrial microvascular perfusion, oxygen tension gradients, and differential metabolic demands of XY versus XX peri-implantation blastocysts. Preconception maternal vascular tone modulates local uterine luminal conditions through endothelial nitric oxide synthase (eNOS) signaling, renin-angiotensin-aldosterone system (RAAS) baseline activation, and nutrient-sensing pathways including AMPK and mTORC1. Male embryos, characterized by accelerated cleavage rates, elevated oxygen consumption, and distinct transcriptomic profiles prior to X-chromosome inactivation, exhibit altered survival dynamics within hyper-perfused or micro-environmentally altered endometrial niches. Integrating these findings through a sex-and-gender-based analysis (SGBA) lens highlights preconception maternal cardiovascular assessment as a key window into early embryonic selection, offering crucial insights for precision reproductive biomedicine and cardiometabolic risk stratification.

Introduction & Cellular Mechanisms


Maternal vascular health prior to fertilization sets the biochemical and hemodynamic template for endometrial receptivity, blastocyst implantation, and early placentation. Traditionally evaluated through the lens of maternal risk stratification for preeclampsia and gestational hypertensive disorders, baseline maternal systemic blood pressure (BP) reflects systemic vascular resistance, arterial stiffness, and autonomic tone. At the cellular level, preconception blood pressure is regulated by endothelial-derived vasoactive factors—principally nitric oxide (NO), prostacyclin, and endothelin-1 (ET-1)—alongside local tissue renin-angiotensin-aldosterone system (RAAS) activation through the angiotensin II type 1 receptor ($AT_1R$).

The translational link between maternal systemic hemodynamics and early embryonic fate lies within the specialized microvascular architecture of the endometrium. Spiral and arcuate arteries undergo dynamic remodeling during the luteal phase under progesterone and estrogen priming. Elevated maternal systemic blood pressure correlates with altered endometrial perfusion pressures, modifying the pericellular microenvironment of the uterine lumen where pre-implantation blastocysts reside.

```
[Maternal Systemic Blood Pressure / Vascular Tone]
│
▼
[Endometrial Microvascular Perfusion & pO2]
│
┌─────────────┴─────────────┐
▼ ▼
[XY Blastocyst] [XX Blastocyst]
- Accelerated Cleavage - Basal Cleavage Rate
- Higher Metabolic Rate - Lower ROS Accumulation
- Enhanced Survival in - Optimized for Basal/Low
High-pO2 Niches pO2 Niches
```

Altered microvascular shear stress and local hypertensive signaling induce subtle alterations in organelle function within endometrial stromal and epithelial cells:
  • Mitochondrial ROS Production: Elevated systemic vascular resistance increases localized production of reactive oxygen species (ROS) within the uterine vascular bed. Excessive ROS disrupts inner mitochondrial membrane potential ($\Delta\Psi_m$), leading to downstream activation of stress-responsive kinases.

  • Nutrient-Sensing Cascades: Hemodynamic-driven shifts in tissue perfusion alter local glucose and amino acid availability. This modulates the balance between AMP-activated protein kinase (AMPK)—a sensor of metabolic stress—and mammalian target of rapamycin complex 1 (mTORC1), which regulates protein synthesis and cellular proliferation in both maternal luminal epithelium and pre-implantation embryos.

  • Pro-inflammatory Cytokine Secretion: Sub-clinical microvascular strain elevates maternal systemic and local concentrations of tumor necrosis factor-alpha ($TNF-\alpha$) and interleukin-6 ($IL-6$), directly impacting maternal-fetal immunomodulatory crosstalk during the critical window of apposition and adhesion.


    • Sex-Dimorphic Regulation & Translational Implications


    The secondary sex ratio (the ratio of male to female live births) is governed by differential male versus female preconception loss or peri-implantation selection. Male (XY) and female (XX) pre-implantation embryos exhibit significant sexual dimorphism prior to gonadal differentiation and classical sex hormone exposure.

    1. Pericellular Oxygen Dynamics and Sex-Selective Implantation


    XY blastocysts possess a distinct transcriptomic profile driven by Y-chromosome locus expressions (e.g., *SRY*, *KDM5D*, *RPS4Y1*) and hyper-transcription of un-methylated autosomal loci. XY embryos demonstrate accelerated cleavage kinetics, higher metabolic turnover, and increased oxygen consumption rates compared to XX counterparts. Elevated maternal preconception systolic blood pressure enhances endometrial perfusion gradients, elevating peri-implantation oxygen tension ($pO_2$). High $pO_2$ environments favor the survival and invasive capacity of high-metabolism XY blastocysts, whereas relative intrauterine hypoxia selectively impairs XY survival due to heightened susceptibility to metabolic stress.

    2. Metabolic Dimorphism and Endometrium-Blastocyst Crosstalk


    Female (XX) embryos, undergoing the process of X-chromosome inactivation (XCI), display dosage compensation mechanisms and elevated expression of X-linked metabolic genes such as glucose-6-phosphate dehydrogenase (*G6PD*) and hypoxanthine phosphoribosyltransferase 1 (*HPRT1*). This grants XX embryos superior antioxidant capacity through NADPH generation, allowing them to withstand lower-perfusion, lower-glucose microenvironments. Conversely, XY embryos rely heavily on exogenous nutrient availability and robust perfusion. Maternal preconception hemodynamics that elevate nutrient flux via microvascular perfusion create an optimal metabolic niche that preferentially supports the energetic demands of XY implantation.

    3. Precision Medicine Perspectives and SGBA


    Integrating sex-and-gender-based analysis (SGBA) into cardiovascular and reproductive medicine requires recognizing maternal cardiometabolic parameters as active modifiers of early selection pressure rather than passive maternal traits.

    ```
    [Preconception Maternal State]
    │
    [Systolic BP / Vascular Tone]
    │
    ┌───────────────┴───────────────┐
    ▼ ▼
    [High Maternal BP] [Low/Normal BP]
    │ │
    [Elevated Uterine pO2] [Standard Uterine pO2]
    │ │
    ▼ ▼
    [XY Survival Advantage] [Balanced XX/XY Survival]
    │ │
    ▼ ▼
    [Skewed Male Sex Ratio] [Baseline Sex Ratio]
    ```

    Clinical implications include:
  • Preconception Risk Stratification: Maternal blood pressure optimization prior to conception represents a potential modifiable target to optimize endometrial receptivity and minimize early pregnancy loss.

  • Biomarker Integration: Preconception assessment of endothelial health (e.g., asymmetric dimethylarginine [ADMA], soluble fms-like tyrosine kinase-1 [sFlt-1], and eNOS polymorphisms) provides mechanistic resolution when determining peri-implantation risks.

  • Sex-Specific Offspring Outcomes: Because preconception cardiovascular profiles alter embryonic selection, male and female offspring selected under differing maternal vascular environments may possess distinct developmental programming trajectories, modifying their long-term cardiometabolic risk profile.


    • Conclusions & Clinical Outlook


    Large-scale prospective evidence establishing a link between maternal preconception blood pressure and offspring sex ratios highlights the sensitivity of early mammalian embryogenesis to maternal systemic vascular tone. The sex-dimorphic survival of pre-implantation embryos is driven by fundamental metabolic, transcriptomic, and physiological differences between XY and XX blastocysts responding to local endometrial microenvironments.

    Future translational research must prioritize single-cell transcriptomic and metabolomic profiling of human blastocysts cultured under varying hemodynamic stress states, combined with non-invasive endometrial imaging techniques (such as contrast-enhanced ultrasound and functional MRI) to evaluate preconception uterine perfusion. Unraveling these maternal-embryonic interaction networks will refine preconception care paradigms, optimize assisted reproductive technologies (ART), and advance precision cardio-obstetric medicine.

    Key Insights


  • Hemodynamic Embryo Selection: Elevated maternal preconception systolic blood pressure skews the secondary sex ratio toward male offspring by altering endometrial microvascular perfusion and local oxygen tension ($pO_2$).

  • Sex-Dimorphic Metabolic Vulnerability: XY blastocysts exhibit accelerated cleavage and higher metabolic rates that thrive in elevated maternal perfusion niches, whereas XX blastocysts maintain superior antioxidant defenses under variable perfusion via X-linked enzyme dosage.

  • Translational Cardiopregnancy Target: Preconception maternal vascular tone serves as an early physiological driver of blastocyst survival, underscoring the necessity of preconception cardiovascular optimization within precision reproductive healthcare.


    • References


    1. Retnakaran, R., Wen, S. W., Tan, H., Zhou, S., Ye, C., Shen, M., & Smith, G. N. (2017). Maternal preconception blood pressure and sex of the baby: A prospective cohort study. *American Journal of Hypertension*, 30(4), 382–388. https://doi.org/10.1093/ajh/hpw165
    2. Gardner, D. K., & Harvey, A. J. (2015). Blastocyst metabolism, cellular physiology, and implications for human assisted reproductive technology. *Reproductive Biomedicine Online*, 31(3), 331–346. https://doi.org/10.1016/j.rbmo.2015.06.009
    3. Bermejo-Alvarez, P., Rizos, D., Lonergan, P., & Gutierrez-Adan, A. (2011). Transcriptional sexual dimorphism during preimplantation development. *Reproduction*, 141(5), 563–571. https://doi.org/10.1530/REP-10-0482